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Acute myocardial injury: 
a novel clinical pattern 
in children with 
COVID-19
Reports of coronavirus disease 2019 
(COVID-19) show that children usually 
have mild clinical signs and less severe 
disease than do adults,1 although the 
reasons for such differences are not yet 
completely understood.2 A previous 
report3 describing paediatric COVID-19 
cases in China showed that 13 (0·6%) 
of 2135 laboratory-confirmed and 
suspected cases were critical, but 
myocardial involvement was not 
noted. At the time of writing, two 
clinical scenarios of severe paediatric 
COVID-19 cases have been reported 
from the UK and Italy: severe shock 
syndrome with hyperinflammation4 
and Kawasaki-like-disease.5
During March 15 to April 25, 
2020, nine patients were admitted 
to our paediatric intensive care 
unit (PICU) for COVID-19; PCR tests 
of nasopharyngeal samples for 
severe acute respiratory syndrome 
coronavirus 2 were positive for all nine 
patients. Five of these patients had 
cardiac injury and mild to moderate 
cardiac dysfunction; we describe 
these patients in this case series. All 
five children (mean age 84·4 months, 
range 2–168) were previously healthy 
and had fever and gastrointestinal 
symptoms as initial signs at home. 
Three patients (1, 4, and 5) had 
fleeting polymorphic rash; in 
patient 5, the rash was associated with 
non-exudative conjunctivitis without 
involvement of the oral mucosa. Only 
patient 2 had respiratory distress 
at home requiring non-invasive 
mechanical support during PICU stay; 
none developed paediatric acute 
respiratory distress syndrome. On 
PICU admission, the main clinical signs 
were tachycardia and hypotension. 
Patient 1 was oligoanuric and patients 
1, 3, and 5 had mild desaturation in 
spontaneous breathing in room air 
(SpO2 94–96%). Blood examinations 
revealed elevated cardiac enzymes 
and inflammation markers. Complete 
demographic, clinical findings, and 
blood test results are shown in the 
appendix. All children had a mild 
to moderate heart dysfunction 
highlighted by reduced ejection 
fraction (mean 47·8%, SD 9·1), and 
all except patient 4 required a short 
course of intravenous epinephrine 
(dose range 0·05–0·1 µg/kg per min), 
which in patient 2 was administered 
with intravenous PDE3 inhibitor 
(milrinone 0·25 µg/kg per min). 
Four children had a midbasal 
hypokinesis of the inferoseptal 
wall and inferior wall. The electro-
cardiogram was abnormal with 
non-specific changes such as sinus 
tachycardia, and ST and T-wave 
abnormalities. Patient 2 developed 
atrial fibrillation and had reversible 
acute kidney injury. Mean length of 
PICU stay was 3·4 days (range 1–5). All 
children were discharged to the ward 
with a normal cardiac function and 
good clinical conditions. Mean length 
of hospital stay was 7·2 days (range 
5–10).
Increasing evidence shows that 
COVID-19 in children has different 
clinical patterns. Our patients did not 
meet all the clinical criteria for classic or 
incomplete Kawasaki disease because 
they had only one or two of the five 
criteria required. It is possible that this 
clinical picture is the mild form of the 
COVID-19-related shock described in 
the UK, which is now being labelled as 
paediatric multisystem inflammatory 
syndrome.6 In both cases, a hyper-
inflammatory state is described with 
cardiac involvement mimicking 
atypical Kawasaki disease. COVID-19 
provokes a cytokine storm;7 in adults 
it mainly compromises the lung with 
acute respiratory distress syndrome and 
affects other organs such as the heart8,9 
to a lesser extent, which condition a 
higher mortality, whereas in children 
it seems to have a different target 
with a prevalent cardiac involvement. 
Interestingly, gastrointestinal symp-
toms occurred in all three groups: 
seven of eight children in the UK,4 
six of ten children in the previous case 
series from Italy,5 and all five children 
in our case series had diarrhoea with or 
without vomiting and abdominal pain. 
Unexpectedly, the substantial increase 
in cardiac enzymes (mainly NT-proBNP, 
which increased to up to 30 times the 
normal value) was not associated with 
severe heart failure.
Our case series reinforces the 
message that children with COVID-19 
should be closely monitored to 
recognise cardiac involvement and to 
prevent a severe and critical course of 
illness.
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